Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	126,674	95,161	48,141	56,215	-	-
Market Cap Growth	49.68%	97.67%	-14.36%	-	-	-
Enterprise Value	122,371	90,913	44,570	52,405	-	-
Last Close Price	1033.80	776.65	379.66	410.70	-	-
PE Ratio	28.77	20.21	10.31	13.43	-	-
Forward PE	22.13	16.54	9.96	11.60	-	-
PS Ratio	5.57	4.17	2.23	2.65	-	-
PB Ratio	4.99	4.08	2.25	2.74	-	-
P/TBV Ratio	4.78	4.11	2.27	2.75	-	-
P/FCF Ratio	33.44	33.62	12.08	-	-
P/OCF Ratio	23.01	15.73	9.41	-	-
PEG Ratio	1.39	1.12	0.98	0.72	-	-
EV/Sales Ratio	5.38	3.98	2.06	2.47	-	-
EV/EBITDA Ratio	19.62	13.59	6.97	8.53	-	-
EV/EBIT Ratio	21.55	14.61	7.42	9.05	-	-
EV/FCF Ratio	31.95	31.12	11.26	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.00	1.24	2.64
Debt / EBITDA Ratio	0.03	0.03	0.03	0.00	1.57	2.24
Debt / FCF Ratio	-	0.06	0.14	0.01	2.91	7.36
Asset Turnover	-	0.82	0.84	0.95	1.01	0.96
Inventory Turnover	-	1.64	1.87	2.07	2.02	1.76
Quick Ratio	-	2.64	2.34	3.10	0.66	0.52
Current Ratio	-	4.37	3.73	4.60	1.15	0.89
Return on Equity (ROE)	-	21.07%	22.28%	29.83%	60.91%	127.84%
Return on Assets (ROA)	-	14.01%	14.52%	16.20%	18.86%	17.33%
Return on Capital (ROIC)	14.30%	17.26%	17.82%	19.34%	22.32%	20.46%
Return on Capital Employed (ROCE)	-	25.80%	27.20%	27.70%	72.40%	106.10%
Earnings Yield	3.49%	4.95%	9.70%	7.45%	-	-
FCF Yield	2.99%	2.97%	8.28%	-	-
Dividend Yield	2.08%	2.90%	5.53%	5.11%	-	-
Payout Ratio	0.00%	58.55%	82.64%	30.73%	-	-
Buyback Yield / Dilution	-0.28%	-0.13%	-4.25%	-9.03%	-	-35.79%
Total Shareholder Return	1.80%	2.77%	1.28%	-3.91%	-	-35.79%

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.